" class="no-js "lang="en-US"> Oncology Archives - Page 3 of 43 - Medtech Alert
Thursday, March 30, 2023

Sort by:


Top Post

NHS Slashes Longest Elective and Cancer Patient Waiting Lists

The number of people waiting over 18 months for NHS care has fallen again despite […]

Propanc Biopharma Confirms PRP Exerts Significant Effects Against Chemoresistant Pancreatic Tumor Cells

Propanc Biopharma, a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and […]

Syndax Pharmaceuticals Announces Two Publications in Nature of Data from the Phase 1 Portion of AUGMENT-101 in Acute Leukemia Patients

Syndax Pharmaceuticals, today announced that data from the Phase 1 portion of the ongoing Phase […]

DEM BioPharma Appoints Miriam Merad, M.D., Ph.D., to Scientific Advisory Board

DEM BioPharma, an immune-oncology company developing therapies that target signals on cancer cells and macrophages […]

Catamaran Bio Selects OmniaBio as Partner to Develop and Manufacture Allogeneic CAR-NK Cell Therapies

Catamaran Bio, a biotechnology company developing off-the-shelf NK cell therapies to treat cancer, and OmniaBio, […]

Cantargia Treats First Triple-Negative Breast Cancer Patient in Randomized Phase II Part of TRIFOUR Trial

Cantargia today reported that, following positive results in the lead-in phase of the clinical phase […]

Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented in "Game Changing" Session at EAU

Telix Pharmaceuticals today announces additional positive results from its completed pivotal Phase III ZIRCON study […]

Bio-Thera Solutions Announces First Patient Dosed in Study for the Treatment of Advanced Solid Tumors

Bio-Thera Solutions, a commercial-stage pharmaceutical company, has announced that dosing has begun in a Phase […]

CNS Pharmaceuticals Continues Momentum in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM with First Patient Enrolled in Switzerland

CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]

QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug

QIAGEN today announced it has entered into a strategic partnership with Servier, a global pharmaceutical […]

Telix to Showcase Additional ZIRCON Phase III Data in Kidney Cancer Imaging and Theranostic Pipeline Developments at EAU

Telix Pharmaceuticals today announces presentations from the Company’s carbonic anhydrase IX (CAIX) targeting kidney and […]

  1. Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Read more
  2. Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Read more
  3. Implantica Launches RefluxStop™ in Italy Read more
  4. Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases Read more
  5. Xeris Biopharma Appoints Ricki Fairley to Board of Directors Read more